Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization) [Cardiac Catheterization]

Conclusions— The benefit from fractional flow reserve–guided complete revascularization in ST-segment–elevation myocardial infarction patients with multivessel disease was dependent on the presence of 3-vessel disease and noninfarct diameter stenosis ≥90% and was particularly pronounced in patients with both of these angiographic characteristics. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01960933.

http://circinterventions.ahajournals.org/cgi/content/short/10/4/e004460?rss=1

Source: Circulation: Cardiovascular Interventions - April 12, 2017 Category: Cardiology Authors: Lonborg, J., Engstrom, T., Kelbaek, H., Helqvist, S., Klovgaard, L., Holmvang, L., Pedersen, F., Jorgensen, E., Saunamaki, K., Clemmensen, P., De Backer, O., Ravkilde, J., Tilsted, H.-H., Villadsen, A. B., Aaroe, J., Jensen, S. E., Raungaard, B., Kober, L Tags: Percutaneous Coronary Intervention, Revascularization Cardiac Catheterization Source Type: research